戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ndiceal mucocele 2 years after risk-reducing salpingo-oophorectomy.
2 eillance for ovarian cancer or risk-reducing salpingo-oophorectomy.
3 c total abdominal hysterectomy and bilateral salpingo-oophorectomy.
4 ration with total hysterectomy and bilateral salpingo-oophorectomy.
5 ty-sparing surgery in the form of unilateral salpingo-oophorectomy.
6 men who had undergone prophylactic bilateral salpingo-oophorectomy (47 women) were matched with mutat
7  approximately 4 years with hysterectomy and salpingo-oophorectomy and adherence to colorectal cancer
8 in 3 of the 98 women who chose risk-reducing salpingo-oophorectomy and peritoneal cancer was diagnose
9 g total abdominal hysterectomy and bilateral salpingo-oophorectomy, and administration of six cycles
10                               Mastectomy and salpingo-oophorectomy are widely used by carriers of BRC
11                       Bilateral prophylactic salpingo-oophorectomy (BPSO) is used widely used to redu
12 associations between hysterectomy, bilateral salpingo-oophorectomy (BSO), and incidence of diabetes i
13 ed with women without surgery; risk-reducing salpingo-oophorectomy decreased breast cancer incidence
14 related gynecologic cancer was longer in the salpingo-oophorectomy group, with a hazard ratio for sub
15 g salpingo-oophorectomy, women who underwent salpingo-oophorectomy had a lower risk of ovarian cancer
16                                 Prophylactic salpingo-oophorectomy has been demonstrated to decrease
17                                              Salpingo-oophorectomy in carriers of BRCA mutations can
18  of malignancies detected after prophylactic salpingo-oophorectomy in women with BRCA mutations.
19 with prophylactic hysterectomy and bilateral salpingo-oophorectomy in women with the Lynch syndrome.
20 hat prophylactic hysterectomy with bilateral salpingo-oophorectomy is an effective strategy for preve
21                                   Preventive salpingo-oophorectomy is currently the only method known
22 ncer in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy is highly likely the appendix.
23                                Risk-reducing salpingo-oophorectomy is often considered by carriers of
24                         Preventive bilateral salpingo-oophorectomy is recommended to women with a BRC
25    Tamoxifen, oral contraceptives, bilateral salpingo-oophorectomy, mastectomy, both surgeries, or su
26 dbearing age, a more conservative unilateral salpingo-oophorectomy may be performed, assuming that ca
27 nsists of primary hysterectomy and bilateral salpingo-oophorectomy, often using minimally invasive ap
28 g 90 individuals who underwent risk-reducing salpingo-oophorectomy, one early-stage ovarian neoplasm
29 f total abdominal hysterectomy and bilateral salpingo-oophorectomy revealed similar estimates (HR, 0.
30                      Risk-reducing bilateral salpingo-oophorectomy (RRBSO) and risk-reducing mastecto
31                                Risk-reducing salpingo-oophorectomy (RRSO) has been widely adopted as
32                                Risk-reducing salpingo-oophorectomy (RRSO) is effective in decreasing
33            Therefore, although risk-reducing salpingo-oophorectomy (RRSO) is standard treatment among
34                                Risk-reducing salpingo-oophorectomy (RRSO) lowers mortality from ovari
35                                Risk-reducing salpingo-oophorectomy (RRSO) was encouraged throughout t
36 as well as risk reduction from risk-reducing salpingo-oophorectomy (RRSO), by CJM and self-identified
37 l risk reduction, particularly risk-reducing salpingo-oophorectomy (RRSO), has become an important co
38  increasingly choose bilateral risk-reducing salpingo-oophorectomy (RRSO).
39 r carriers of these mutations, risk-reducing salpingo-oophorectomy significantly reduces morbidity an
40 sk of ovarian cancer, prophylactic bilateral salpingo-oophorectomy significantly reduces the incidenc
41 with women who did not undergo risk-reducing salpingo-oophorectomy, undergoing salpingo-oophorectomy
42 a lower risk of breast cancer; risk-reducing salpingo-oophorectomy was associated with a lower risk o
43 k-reducing salpingo-oophorectomy, undergoing salpingo-oophorectomy was associated with lower all-caus
44  relationship of risk-reducing mastectomy or salpingo-oophorectomy with cancer outcomes.
45 ctively compared the effect of risk-reducing salpingo-oophorectomy with that of surveillance for ovar
46 with women who did not undergo risk-reducing salpingo-oophorectomy, women who underwent salpingo-ooph

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。